- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Lomitapide, as an MTP inhibitor, has clear contraindications for patients with moderate to severe liver disease, pregnant women, and lactating ...
During treatment with Lometapine, side effects such as nausea, bloating, and elevated transaminase levels may occur, which need to be managed t...
Lometapai is an MTP inhibitor used to treat homozygous familial hypercholesterolemia. During medication, special attention should be paid to ...
Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor primarily used as an adjuvant therapy in adult patients with homozygou...
If side effects such as fever, diarrhea, or vomiting occur during the use of Evrysdi tablets, graded management measures should be taken accord...
Evrysdi (Risperidone tablets) has clear contraindications in patients with severe liver dysfunction and pregnant women, and strict adherence to...
As an SMN2 splicing modifier, special attention should be paid to hepatotoxicity, rash risk, and drug interactions when using Evrysdi tablets. ...
Evrysdi (Risperidone tablets) is an SMN2 splicing modifier used for the treatment of spinal muscular atrophy (SMA). This drug improves the pati...
The contraindications for Pacritinib mainly include patients with severe heart block and active bleeding, and strict adherence to contraindicat...
Pacritinib is a JAK2/IRAK1 inhibitor used to treat myelofibrosis with severe thrombocytopenia, and strict adherence to dosage regimens and moni...
